BRM-TARGETED COMPOUNDS AND RELATED METHODS OF USE

DE602021031131T2Active Publication Date: 2025-05-21PRELUDE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602021031131
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-06-09
Filing Date
2021-06-09
Publication Date
2025-05-21
Estimated Expiration
2041-06-09
Patent Text Reader

Abstract

The present disclosure provides bifunctional compounds comprising a target protein binding moiety and a E3 ubiquitin ligase binding moiety, and associated methods of use.
Need to check novelty before this filing date? Find Prior Art